Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guazzi, M.
Right arrow Articles by Guazzi, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guazzi, M.
Right arrow Articles by Guazzi, M. D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:1802-1806, 2002
© 2002 by the American Diabetes Association, Inc.


Emerging Treatment and Technologies
Original Article

Insulin Improves Alveolar-Capillary Membrane Gas Conductance in Type 2 Diabetes

Marco Guazzi, MD, PHD, Iacopo Oreglia, MD and Maurizio D. Guazzi, MD, PHD

From the Institute of Cardiology, University of Milan, Milan, Italy

OBJECTIVE—In type 1 diabetes, lung diffusing capacity for carbon monoxide (DLCO) may be impaired, and insulin has been shown to be beneficial in cases in which near-normal metabolic control is achieved. An influence of insulin, per se, on the alveolar-capillary membrane conductance is unexplored. We aimed at testing this possibility.

RESEARCH DESIGN AND METHODS—We studied 19 life-long nonsmoking, asymptomatic patients with type 2 diabetes and normal cardiac function, whose GHb averaged 6.2 ± 0.3% with diet and hypoglycemic drugs. DLCO and its subcomponents (alveolar capillary membrane conductance [DM] and pulmonary capillary blood volume available for gas exchange [Vc]), vital capacity (VC), forced expiratory volume 1 s (FEV1), cardiac output (CO), ejection fraction (EF), pulmonary wedge pressure (WPP), and pulmonary arteriolar resistance (PAR) were determined before and within 60 min after infusion of 50 ml saline + 10 IU of regular insulin or after saline alone on 2 consecutive days (random block design). Glycemia was kept at baseline levels during experiments by dextrose infusion.

RESULTS—Percent of normal predicted DLCO averaged 84.2 ± 7.9% and in 14 patients was <100%. Insulin infusion, not saline alone, improved (P < 0.01) DLCO (12%) and DM (14%) and raised DLCO to 98% of the normal predicted value. There were no variations in VC, FEV1, CO, EF, WPP, or PAR, suggesting that the influences of the hormone on gas transfer were not mediated by changes in spirometry, volumes, and hemodynamics of the lung.

CONCLUSIONS—Several cases of type 2 diabetes present with increased impedance to gas transfer across the alveolar-capillary membrane, and hypoglycemic drugs do not prevent this inconvenience. Insulin, independently of the metabolic effects, acutely improves gas exchange, possibly through a facilitation of the alveolar-capillary interface conductance.

Abbreviations: CO, cardiac output • CV, coefficient of variation • DLCO, lung diffusing capacity for carbon monoxide • DM, alveolar capillary membrane conductance • EF, ejection fraction • FEV1, forced expiratory volume 1 s • SVR, systemic vascular resistance • PAR, pulmonary arteriolar resistance • Va, alveolar volume • Vc, pulmonary capillary blood volume available for gas exchange • VC, vital capacity, WPP, pulmonary wedge pressure


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
L. Kuitert
The lung in diabetes - yet another target organ?
Chronic Respiratory Disease, May 1, 2008; 5(2): 67 - 68.
[PDF]


Home page
Chronic Respiratory DiseaseHome page
A Kaparianos, E Argyropoulou, F Sampsonas, K Karkoulias, M Tsiamita, and K Spiropoulos
Pulmonary complications in diabetes mellitus
Chronic Respiratory Disease, May 1, 2008; 5(2): 101 - 108.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Brown, M. Gallacher, R. E. Olver, and S. M. Wilson
The regulation of selective and nonselective Na+ conductances in H441 human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L942 - L954.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Bonay, C. Bancal, D. de Zuttere, F. Arnoult, G. Saumon, and F. Camus
Normal Pulmonary Capillary Blood Volume in Patients With Chronic Infiltrative Lung Disease and High Pulmonary Artery Pressure
Chest, November 1, 2004; 126(5): 1460 - 1466.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Guazzi, G. Tumminello, M. Matturri, and M. D. Guazzi
Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1044 - 1050.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Guazzi
Alveolar-Capillary Membrane Dysfunction in Heart Failure: Evidence of a Pathophysiologic Role
Chest, September 1, 2003; 124(3): 1090 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Boulbou, K. Gourgoulianis, P. A. Molyvdas, M. Guazzi, R. Brambilla, S. De Vita, and M. D. Guazzi
Insulin Effect on Lung Diffusion: NO Pathway
Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 398 - 399.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.